$RXMD's CEO discusses the third quarter 2019 finan
Post# of 25327
(Total Views: 79)
Posted On: 11/22/2019 2:59:31 PM
$RXMD's CEO discusses the third quarter 2019 financial highlights, the outlook for the Company in 2020, the renegotiated Family Physicians Rx (FPRX) acquisition, reducing price by 36%, saving shareholders $1.1 million, and much more.
https://twitter.com/ProgressCareUS/status/119...6002489344
https://twitter.com/ProgressCareUS/status/119...6002489344
(0)
(0)Scroll down for more posts ▼